Dls Merrill Healthcare & Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2017
About Dls Merrill Healthcare & Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ishwarlal Soni, Mukesh Soni, and Anamika Soni serve as directors at the Company.
- CIN/LLPIN
U24233MH2013PLC248823
- Company No.
248823
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2013
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dls Merrill Healthcare & Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ishwarlal Soni  | Director | 03-Oct-2013 | Current |
| Mukesh Soni | Director | 03-Oct-2013 | Current |
| Anamika Soni | Director | 03-Oct-2013 | Current |
Financial Performance of Dls Merrill Healthcare & Pharma.
Dls Merrill Healthcare & Pharma Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dls Merrill Healthcare & Pharma?
In 2017, Dls Merrill Healthcare & Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chamber Of Infotech & CommunicationsActive 10 years 9 monthsIshwarlal Soni, Mukesh Soni and 1 more are mutual person
- Federation Of Builders & DevelopersActive 9 years 11 months
Ishwarlal Soni, Mukesh Soni and 1 more are mutual person
- Property Agents Association Of IndiaActive 8 years 11 months
Mukesh Soni and Anamika Soni are mutual person
- Shree Gajanan Tenants & Owners Welfare AssociationActive 9 years 11 months
Mukesh Soni and Anamika Soni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dls Merrill Healthcare & Pharma?
Unlock and access historical data on people associated with Dls Merrill Healthcare & Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dls Merrill Healthcare & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dls Merrill Healthcare & Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
